Enhanced Curable Radiopaque Substances for 3D Printing

Publication ID: 24-11857649_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Curable Radiopaque Substances for 3D Printing,” Published Technical Disclosure No. 24-11857649_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857649_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,649.

Summary of the Inventive Concept

This invention introduces a series of direct improvements and enhancements to curable radiopaque substances, enabling faster, safer, and more efficient production of materials with improved optical properties for various applications.

Background and Problem Solved

The original patent disclosed a curable radiopaque substance with limitations in terms of print speed, shelf life, and radiopacity. The present inventive concept addresses these limitations by introducing novel compositions, methods, and systems that enhance the performance of the curable substance in 3D printing applications.

Detailed Description of the Inventive Concept

The new inventive concept comprises four key aspects: (1) a system for producing curable and radiopaque materials using 3D printing devices, (2) a method for enhancing radiopacity by mixing with rare earth compounds and exposing to radiation, (3) a curable substance with improved shelf life due to the addition of a UV stabilizer, and (4) a system for optimizing print speed by adjusting viscosity and printing parameters. These innovations enable the production of materials with improved optical properties, faster print speeds, and enhanced radiopacity.

Novelty and Inventive Step

The new claims introduce novel combinations of compounds, methods, and systems that improve upon the original patent's limitations. Specifically, the use of rare earth compounds, UV stabilizers, and optimized print speed parameters constitutes a non-obvious and innovative step forward in the field of curable radiopaque substances.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different rare earth compounds, varying the concentration of UV stabilizers, or incorporating additional additives to further enhance the performance of the curable substance. Variations may also involve adapting the system and method for use in different 3D printing technologies or applications.

Potential Commercial Applications and Market

The enhanced curable radiopaque substances and related systems and methods have significant commercial potential in the dental, medical, and industrial 3D printing markets, where the demand for high-performance materials with improved optical properties is growing.

CPC Classifications

SectionClassGroup
A A61 A61K6/70
A A61 A61K6/847
A A61 A61K6/887
C C08 C08F220/12

Field of Art

Dental and medical materials science, specifically polymer chemistry focused on curable radiopaque substances for medical and dental applications, involving expertise in monomer chemistry, radiation curing, and additive manufacturing technologies

Person of Ordinary Skill (PHOSITA) Profile

A materials scientist or chemical engineer with advanced degree, specialized knowledge in polymer chemistry, experience with radiation-curable compositions, familiar with 3D printing technologies and medical material formulation techniques

Obviousness Rationale

A person having ordinary skill would recognize that the PTD's variations represent predictable extensions of the source patent's core technology, involving standard optimization techniques such as adding stabilizers, exploring compound variations, and adapting manufacturing processes that are well-known in polymer and medical materials engineering.

Obvious Combinations & Variations

Source Patent Element
Polymerizable monomers with radiopaque compounds
PTD Variation
Adding UV stabilizers to improve shelf life of curable substance
Obviousness Reasoning
Adding stabilizers to polymer systems is a known technique to prevent degradation, and a PHOSITA would find it obvious to extend the source patent's composition with standard preservation methods
Source Patent Element
Radiopaque compounds including strontium, zirconium, lead, barium, bismuth compounds
PTD Variation
Incorporating rare earth compounds to enhance radiopacity
Obviousness Reasoning
Exploring additional radiopaque compounds within a known class represents a routine design choice for optimizing material properties, predictable to a skilled practitioner
Source Patent Element
Curable substance for material production
PTD Variation
3D printing system with digital data model generation for optimized radiopacity
Obviousness Reasoning
Adapting known polymer compositions to emerging manufacturing technologies like 3D printing is an expected progression in materials engineering, representing a predictable technological evolution
Source Patent Element
Free-radically curable monomers
PTD Variation
Method for exposing curable substance to radiation to enhance radiopacity
Obviousness Reasoning
Manipulating radiation exposure parameters for material modification is a standard technique in polymer chemistry, representing a predictable optimization approach
Source Patent Element
Polymerization monomers with radiopaque compounds
PTD Variation
Optimizing viscosity and printing parameters for improved 3D printing speed
Obviousness Reasoning
Adjusting material properties to improve manufacturing processes is a routine engineering task, predictable to a skilled practitioner familiar with polymer processing techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857649 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations obvious, as they represent predictable combinations of known techniques in polymer chemistry and additive manufacturing, involving routine optimization of material composition, processing parameters, and manufacturing methods without requiring inventive insight beyond the ordinary capabilities of a skilled practitioner in the field.

Original Patent Information

Patent NumberUS 11,857,649
TitleCurable radiopaque substance
Assignee(s)Merz Dental GmbH